High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study

High-dose intravenous steroid treatment (HDIST) represents the first choice of treatment for multiple sclerosis (MS) relapses. Chronic oral glucocorticoid (GC) administration correlates with bone loss whereas data regarding HDIST in MS are still conflicting. Twenty-five newly diagnosed MS patients (...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	George Simeakis, Maria Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, Gregory Kaltsas, Evangelos Terpos
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2023-02-01
Serie:	Biomedicines
Ämnen:	multiple sclerosis glucocorticoids BMD cytokines periostin 25-hydroxyvitamin D
Länkar:	https://www.mdpi.com/2227-9059/11/2/603
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!